Mesenchymal stem cell origin contributes to the antitumor effect of oncolytic virus carriers.
Sukegawa M, Miyagawa Y, Kuroda S, Yamazaki Y, Yamamoto M, Adachi K, Sato H, Sato Y, Taniai N, Yoshida H, Umezawa A, Sakai M, Okada T.
Sukegawa M, et al. Among authors: sakai m.
Mol Ther Oncol. 2024 Oct 18;32(4):200896. doi: 10.1016/j.omton.2024.200896. eCollection 2024 Dec 19.
Mol Ther Oncol. 2024.
PMID: 39554905
Free PMC article.